Rchr
J-GLOBAL ID:201801000020900685   Update date: Apr. 24, 2024

Shimakami Tetsuro

シマカミ テツロウ | Shimakami Tetsuro
Affiliation and department:
Research field  (1): Gastroenterology
Research theme for competitive and other funds  (8):
  • 2022 - 2025 Identification of driver genes controlling metastatic potential in the evolution of hepatocellular carcinoma
  • 2020 - 2024 Investigation on Molecular Mechanisms of Liver Diseases Caused by Hepatitis B and D Viruses Coinfection
  • 2015 - 2018 Identification of biomarkers to predict HCC development after successful treatment of viral hepatitis
  • 2015 - 2018 長鎖ノンコーディングRNAを基軸としたC型慢性肝疾患の病態制御
  • 2015 - 2017 C型肝炎ウイルスNS3変異体出現の分子生物学的機構の解明
Show all
Papers (110):
  • Junyan Lyu, Hikari Okada, Hajime Sunagozaka, Kazunori Kawaguchi, Tetsuro Shimakami, Kouki Nio, Kazuhisa Murai, Takayoshi Shirasaki, Mika Yoshida, Kuniaki Arai, et al. Potential utility of l-carnitine for preventing liver tumors derived from metabolic dysfunction-associated steatohepatitis. Hepatology communications. 2024. 8. 5
  • Tomoyuki Hayashi, Kotaro Hayashi, Takeshi Terashima, Masaki Nishitani, Noriaki Orita, Masaki Miyazawa, Akihiro Seki, Hidetoshi Nakagawa, Kouki Nio, Noriho Iida, et al. Photodynamic therapy with talaporfin sodium for endoscopically unresectable gastric cancer using a novel simultaneous light-emitting method. DEN open. 2024. 4. 1. e334
  • Ryogo Shimizu, Kazuhisa Murai, Kensuke Tanaka, Yuga Sato, Naho Takeda, Saki Nakasyo, Takayoshi Shirasaki, Kazunori Kawaguchi, Tetsuro Shimakami, Kouki Nio, et al. Nucleos(t)ide analogs for hepatitis B virus infection differentially regulate the growth factor signaling in hepatocytes. Hepatology Communications. 2024. 8. 1
  • Masaki Miyazawa, Masahiro Yanagi, Tomoyoshi Chiba, Hidenori Kido, Toshiki Matsuo, Masaki Nishitani, Noriaki Orita, Noboru Takata, Tomoyuki Hayashi, Akihiro Seki, et al. Post-allogeneic Hematopoietic Stem Cell Transplantation Portal Hypertension Not Associated with Liver Cirrhosis, Veno-occlusive Disease, or Graft-versus-host Disease: A Case Report. Internal medicine (Tokyo, Japan). 2023
  • Makoto Yamamoto, Takeshi Terashima, Tatsuya Yamashita, Akihiro Seki, Hidetoshi Nakagawa, Kouki Nio, Tetsuro Shimakami, Hajime Takatori, Kuniaki Arai, Eishiro Mizukoshi, et al. Successful second-line treatment with cabozantinib for hepatocellular carcinoma harboring cytoplasmic mesenchymal-epithelial transition factor amplification. Hepatology research : the official journal of the Japan Society of Hepatology. 2023
more...
MISC (226):
  • 林智之, 西谷雅樹, 織田典明, 宮澤正樹, 高田昇, 岡藤啓史, 玉井利克, 中河秀俊, 関晃裕, 丹尾幸樹, et al. 潰瘍性大腸炎の内視鏡的寛解予測におけるLRGの検討~活動性評価目的の内視鏡検査は不要となるか~. 日本消化器病学会雑誌(Web). 2023. 120
  • 丹尾幸樹, 島上哲朗, 山下太郎. Laminin γ2 monomer as a diagnostic and prognostic biomarker in hepatocellular carcinoma. 肝胆膵. 2023. 86. 5
  • 島上哲朗, 丹尾幸樹, 山下太郎. 血清LG2m値によるC型肝炎SVR後患者の肝発がんリスク層別化に関する解析. 肝臓. 2023. 64. Supplement 1
  • 山本信, 林智之, 鷹取元, 山下竜也, 井城敬一郎, 竹内勇太, 千葉智義, 木戸秀典, 松尾俊紀, 三浦雅, et al. 難治性胃食道逆流症に対して内視鏡的噴門部粘膜焼灼術を施行した一例. Endoscopic Forum for Digestive Disease. 2023. 39. 1
  • 下出哲弘, 川口和紀, 本多政夫, 岡田光, 関晃裕, 丹尾幸樹, 島上哲朗, 酒井佳夫, 水腰英四郎, 金子周一, et al. HGFを介した内皮細胞によるHBV感染肝細胞のウイルス複製への影響. 肝細胞研究会プログラム・抄録集. 2023. 30th
more...
Education (1):
  • 1998 - 2004 Kanazawa University
Professional career (1):
  • 医学博士 (金沢大学)
Work history (2):
  • 2010/06 - 2011/03 The University of North Carolina at Chapel Hill The Lineberger Comprehensive cancer Center Post-doc fellow
  • 2008/03 - 2010/05 The University of Texas Medical Branch at Galveston Department of Microbiology and Immunology Post-doc fellow
Awards (5):
  • 2014 - ブリストル・マイヤーズ スクイブ Hepatitis Meeting in Japan 2014 HMJ award
  • 2014 - 持田記念医学薬学振興財団 持田記念研究助成金
  • 2013 - 武田科学振興財団 武田科学振興財団医学系研究奨励
  • 2013 - 日本消化器病学会 日本消化器病学会研究助成金
  • 2012 - ウイルス肝炎研究財団 ウイルス肝炎研究財団研究奨励賞
Association Membership(s) (4):
THE JAPAN SOCIETY OF HEPATOLOGY ,  JAPAN GASTROENTEROLOGICAL ENDOSCOPY SOCIETY ,  JAPANESE SOCIETY OF GASTROENTEROLOGY ,  THE JAPANESE SOCIETY OF INTERNAL MEDICINE
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page